Talpaz M - Search Results

1

NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.

O'Brien S, Berman E, Borghaei H, Deangelo DJ, Devetten MP, Devine S, Erba HP, Gotlib J, Jagasia M, Moore JO, Mughal T, Pinilla-Ibarz J, Radich JP, Shah Md NP, Shami PJ, Smith BD, Snyder DS, Tallman MS, Talpaz M, Wetzler M; National Comprehensive Cancer Network. O'Brien S, et al. Among authors: talpaz m. J Natl Compr Canc Netw. 2009 Oct;7(9):984-1023. doi: 10.6004/jnccn.2009.0065. J Natl Compr Canc Netw. 2009. PMID: 19878641 No abstract available.

2

Bone marrow hypoplasia and aplasia complicating interferon therapy for chronic myelogenous leukemia.

Talpaz M, Kantarjian H, Kurzrock R, Gutterman JU. Talpaz M, et al. Cancer. 1992 Jan 15;69(2):410-2. doi: 10.1002/1097-0142(19920115)69:2<410::aid-cncr2820690222>3.0.co;2-v. Cancer. 1992. PMID: 1370212

3

Polyclonal hematopoiesis in interferon-induced cytogenetic remissions of chronic myelogenous leukemia.

Claxton D, Deisseroth A, Talpaz M, Reading C, Kantarjian H, Trujillo J, Stass S, Gooch G, Spitzer G. Claxton D, et al. Among authors: talpaz m. Blood. 1992 Feb 15;79(4):997-1002. Blood. 1992. PMID: 1371081 Free article.

4

Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors.

Estrov Z, Kurzrock R, Estey E, Wetzler M, Ferrajoli A, Harris D, Blake M, Gutterman JU, Talpaz M. Estrov Z, et al. Among authors: talpaz m. Blood. 1992 Apr 15;79(8):1938-45. Blood. 1992. PMID: 1373331 Free article.

5

Molecular approaches to purging of chronic myelogenous leukemia marrow in autologous transplantation.

Yuan T, Zhou YQ, Herst CV, Reading C, Ellersen D, Etkin M, Khouri I, Kantarjian H, Talpaz M, Deisseroth A. Yuan T, et al. Among authors: talpaz m. Prog Clin Biol Res. 1992;377:227-30. Prog Clin Biol Res. 1992. PMID: 1438419 No abstract available.

6

The modulatory hematopoietic activities of leukemia inhibitory factor.

Estrov Z, Talpaz M, Wetzler M, Kurzrock R. Estrov Z, et al. Among authors: talpaz m. Leuk Lymphoma. 1992 Sep;8(1-2):1-7. doi: 10.3109/10428199209049811. Leuk Lymphoma. 1992. PMID: 1493463 Review.

7

Myelokathexis: normalization of neutrophil counts and morphology by GM-CSF.

Wetzler M, Talpaz M, Kellagher MJ, Gutterman JU, Kurzrock R. Wetzler M, et al. Among authors: talpaz m. JAMA. 1992 Apr 22-29;267(16):2179-80. JAMA. 1992. PMID: 1556785 No abstract available.

8

Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy.

Lee MS, Kantarjian H, Talpaz M, Freireich EJ, Deisseroth A, Trujillo JM, Stass SA. Lee MS, et al. Among authors: talpaz m. Blood. 1992 Apr 15;79(8):1920-3. Blood. 1992. PMID: 1562719 Free article.

9

Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabine.

Kantarjian HM, Keating MJ, Estey EH, O'Brien S, Pierce S, Beran M, Koller C, Feldman E, Talpaz M. Kantarjian HM, et al. Among authors: talpaz m. J Clin Oncol. 1992 May;10(5):772-8. doi: 10.1200/JCO.1992.10.5.772. J Clin Oncol. 1992. PMID: 1569449

10

Minimal residual disease in interferon-treated chronic myelogenous leukemia: results and pitfalls of analysis based on polymerase chain reaction.

Dhingra K, Kurzrock R, Kantarjian H, Baine R, Eastman PS, Ku S, Gutterman JU, Talpaz M. Dhingra K, et al. Among authors: talpaz m. Leukemia. 1992 Aug;6(8):754-60. Leukemia. 1992. PMID: 1640725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

604 results

Search Page

Filters